Acute Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage

Why output has slowed:

• Catheter obstruction - clot, brain debris, or choroid plexus occluding the fenestrations. This is the most common early cause.
• Catheter malposition - outside the ventricle, in the parenchyma, or with the tip against the ventricular wall.
• Ventricular collapse - over-drainage can collapse the ventricle around the catheter.
• Loss of the CSF pathway - worsening cerebral edema or rebleeding obstructing the foramen of Monro.
• System issue - kinked tubing, closed stopcock, or a leveled transducer that is off, giving a falsely low reading.

Systematic evaluation of rising ICP:

1. Check the system first: level and zero the transducer, check tubing for kinks, confirm the stopcock is open. Re-zero at the level of the tragus.
2. Check the patient: ensure the head is elevated 30 degrees, midline, with no tight cervical collar or tape obstructing venous drainage. Suction the airway briefly if secretions are audible; treat coughing or biting.
3. Sedation and ventilation: ensure adequate sedation and analgesia; check that PaCO2 is in the 35–40 range, not hypercapnic. Avoid hypoxia.
4. Examine the pupils and motor response - a new fixed pupil or a drop in GCS changes urgency.
5. Flush the catheter gently with 2–3 mL of preservative-free saline under sterile technique to clear clot; if resistance, do not force.
6. Image - a non-contrast CT to look for rebleeding, infarct, or hydrocephalus progression, and to confirm catheter position.
7. Escalate - if the catheter cannot be salvaged, replace it or place a new one; consider a second drain on the contralateral side if the ventricles are asymmetric.

Tiered management:

Tier 1 - basics:

• Head of bed 30 degrees, midline head, loose collar.
• Analgesia and sedation - target a RASS of −2 to −3; propofol or fentanyl/midazolam.
• Normocapnia (PaCO2 35–40), normoxia, normothermia, normoglycemia, normonatremia.
• Seizure prophylaxis short course (e.g., levetiracetam) - though evidence for routine prophylaxis is limited, many use it early after SAH.
• Avoid hypotension - keep CPP >60–70 mmHg with norepinephrine; this patient's BP is adequate but watch for over-treatment.

Tier 2 - osmotic therapy:

• Hypertonic saline (3% boluses or continuous) or mannitol (0.25–1 g/kg bolus) for ICP >20–25. Monitor sodium and osmolality; hypertonic saline is often preferred in SAH because it supports volume status.
• CSF drainage - intermittent drainage guided by ICP rather than continuous, to avoid over-drainage and rebleed risk.

Tier 3 - refractory:

• Neuromuscular blockade (cisatracurium) for 24–48 hours.
• Barbiturate coma or therapeutic hypothermia in refractory cases, with EEG monitoring.
• Decompressive craniectomy as a last resort in selected patients.

When to consider permanent diversion:

• Persistent dependence on the ventriculostomy beyond 10–14 days, or failure of a trial of clamping, suggests chronic hydrocephalus and the need for a ventriculoperitoneal shunt.
• Predictors of shunt dependence: advanced age, poor grade, thick intraventricular blood, and a high initial opening pressure. This patient has several.
• Trial clamping should be done with ICP monitoring and clinical checks; if ICP rises or the patient deteriorates, reopen and plan a shunt.
• Alternative: endoscopic third ventriculostomy in selected patients, though shunt is more common after SAH.

Evaluation:

• Delayed cerebral ischemia (DCI) from vasospasm is the leading concern, typically days 3–14 after hemorrhage. New focal deficit in a previously stable patient is the classic presentation.
• Exclude other causes: rebleeding (CT), hydrocephalus (CT and ICP), seizure (EEG), metabolic derangement (sodium, glucose), and infection.
• CT angiography to assess for vasospasm; CT perfusion can show a perfusion deficit. Transcranial Doppler is a useful bedside adjunct - elevated velocities in the MCA suggest spasm, though it is operator-dependent.
• Catheter angiography is the definitive test and allows intervention.

Management:

• Optimize cerebral perfusion: maintain euvolemia (avoid both hypovolemia and overload), target MAP with vasopressors to keep CPP adequate. Do not induce hypertension without confirming the aneurysm is secured - if it is not, this risks rebleeding.
• Nimodipine - continue the full course (21 days) at 60 mg every 4 hours. It improves outcomes but does not reverse established vasospasm; it is prophylactic. If hypotension occurs, dose reduction or a switch to enteral administration may be needed, but avoid stopping it.
• Endovascular therapy for symptomatic vasospasm: intra-arterial vasodilators (e.g., verapamil, nicardipine) or balloon angioplasty for proximal large-vessel spasm. This is the definitive treatment for refractory DCI.
• Avoid induced hypertension as a first-line strategy unless the aneurysm is secured and the patient is not responding to euvolemia; the evidence for hypertensive therapy is weak.
• Monitor closely - hourly neuro checks, daily TCDs, and repeat imaging if the deficit progresses.